Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
- PMID: 20692762
- PMCID: PMC2980557
- DOI: 10.1016/j.canlet.2010.07.014
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
Abstract
Chronic gastric infection by the gram-negative bacterium Helicobacter pylori is strongly associated with the development of distal gastric carcinoma and gastric mucosal lymphoma in humans. Eradication of H. pylori with combination antibiotic therapy cures most cases of gastric lymphoma and slows progression to gastric adenocarcinoma. H. pylori promotes gastric neoplasia, principally via the induction of an intense gastric inflammatory response that lasts over decades. This persistent inflammatory state produces chronic oxidative stress and adaptive changes in gastric epithelial and immune cell pathobiology that in a minority of infected subjects eventually proceeds to frank neoplastic transformation.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
Conflict of Interest Statement
No of the authors have any potental conflicts of interest that could nnapropriately nfluence (bias) their work.
Figures
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108. - PubMed
-
- Quiros RM, Bui CL. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am. 2009;89:79–96. viii. - PubMed
-
- Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–3044. - PubMed
-
- Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175–1186. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
